Recruiting
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
NCT07484022
- Conditions
- Advanced Urothelial Cancer, Carcinoma, Carcinoma, Transitional Cell, +7 more
- Locations
-
- City of Hope Duarte, California, United States
- COH Lennar Irvine, California, United States
- Orlando Health Orlando, Florida, United States
- COH Atlanta Tucker, Georgia, United States